スマート吸入器市場の2030年までの予測-製品別、適応症別（喘息、慢性閉塞性肺疾患）、流通チャネル別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、世界のスマート吸入器市場は2023年に14億2,000万米ドルを占め、予測期間中にCAGR 9％で成長し、2030年には26億米ドルに達すると予測されています。

スマート吸入器は、慢性呼吸器疾患を効果的に管理し、患者のライフスタイルを向上させるために、Bluetoothを介してモバイルアプリとペアリングするように作られたガジェットです。さらに、ユーザーの過去の投与履歴に基づいて、これらのスマートデバイスは、リマインダーやアラートを送信することができます。喘息、嚢胞性線維症、慢性閉塞性肺疾患などの呼吸器疾患が一般的になりつつあり、スマート吸入器の需要が急激に高まっています。

WHOの2021年報告によると、喘息は主要な非感染性疾患（NCD）であり、子供と大人の両方に影響を及ぼし、2019年には推定2億6,200万人が罹患し、同年に461000人が死亡しています。

市場力学：

促進要因

喘息の罹患率の上昇

大気汚染と喫煙習慣の増加により喘息とCOPDが一般的になりつつあり、スマート吸入器の市場需要を牽引しています。ODPHP Office of Disease Prevention and Health Promotionの推計によると、2020年には世界中で3億3,900万人以上の喘息患者が発生し、そのうち2,500万人がアメリカ人で、COPDの診断数は1,480万人です。喘息は子供と高齢者に最も多く見られる病気です。この非伝染性疾患は、喫煙習慣の増加や世界の大気汚染レベルの上昇によって広がっています。

抑制要因

データ漏洩のリスク

スマート吸入器のワイヤレス接続と患者のデータを記録する能力の結果、データ漏洩と誤用のリスクが著しく高まっています。さらに、スマート吸入器は患者や医師の受容度が非常に低いため、市場拡大の妨げになると予想されます。

機会：

医療機器におけるデジタル技術の利用拡大

予測期間中、医療機器におけるデジタル技術の採用が増加し、ドラッグデリバリーデバイスが治療対策に有効であることから、市場成長が加速すると予測されます。これに加えて、喘息やCOPDのような呼吸器疾患の有病率の増加が、デジタル吸入器の採用拡大に大きな機会をもたらすと予測されています。例えば、米国疾病予防管理センター（CDC）の調査によると、2016年には米国に2,650万人の喘息患者がいたと推定されています。前述の要因は、これらのスマート吸入器の市場拡大に大きく拍車をかけると思われます。

脅威

代替手動吸入器の存在

スマート吸入器の利点が拡大しているにもかかわらず、代替製品として手動吸入器が存在するため、市場の拡大がある程度制限される可能性があります。スマート吸入器の市場拡大を阻害するもう1つの重要な要因は、新興経済諸国の民衆におけるデジタル吸入器の使用に関する認識不足です。

COVID-19の影響：

COVID-19の世界の発生は、スマート吸入器分野の市場参入企業に有利な成長機会をもたらすと予想されます。COPDや喘息の患者がCOVID-19によって入院するリスクが高いため、パンデミックは市場に好影響を与えました。このように、COVID-19患者の増加と呼吸器疾患の負担により、スマート吸入器の需要や採用がこの時期に高まっています。

病院薬局セグメントは予測期間中に最大になると予想される：

予測期間中、病院薬局セグメントが最大の市場シェアを占めると予測されます。病院で治療を受けている患者層は、病院薬局へのアクセスが容易です。また、多くのドラッグデリバリーシステムメーカーが病院薬局と販売契約を結んでいます。したがって、予測期間中、前述の要因は、スマート吸入器を販売する病院薬局の市場がプラスの成長軌道を描くことを強く示唆しています。

慢性閉塞性肺疾患（COPD）セグメントは、予測期間中に最も高いCAGRが見込まれる：

COPD患者数の世界の拡大により、市場成長は今後数年間で有利な成長が見込まれます。例えば、世界保健機関（WHO）は、2019年の世界第3位の死因はCOPDであり、323万人以上の命が奪われたと推定しています。さらに、長期にわたるタバコの使用、屋内空気汚染、有害なガスや粒子、職業性粉塵など、多くの危険因子がCOPDの有病率に影響し、継続的なケア管理が必要となります。その結果、予測される期間中、COPD有病率の上昇と効果的な治療に対するニーズの高まりが、このセグメントの需要を牽引することになります。

最大シェアを占める地域

北米地域市場は予測期間中、世界のスマートシェルフ市場で最も高いシェアを占めると予測され、これは同地域の国々における主要市場プレイヤーの活動が活発化していることに起因しています。北米のスマートシェルフ市場には、先進技術を組み込んだインテリジェントな棚システムの導入と展開が含まれ、小売環境におけるショッピング体験の向上、在庫管理の改善、リアルタイムのデータ分析を提供します。北米の小売業者は、業務を合理化し、顧客エンゲージメントを強化するために、自動化とデジタル化をますます取り入れています。スマートシェルフはリアルタイムの在庫追跡を可能にするため、小売業者は在庫レベルを最適化し、在庫切れを減らし、全体的な在庫管理効率を向上させることができます。

CAGRが最も高い地域：

高齢者人口の多さ、可処分所得の増加、ヘルスケアコストの上昇、数々の開発イニシアティブにより、アジア太平洋地域は急速な成長が見込まれています。新興経済諸国がヘルスケアIT開発費を増加させていることも、同地域の成長を後押ししています。さらに、アジア太平洋地域のスマート吸入器市場は、インドと中国で急速に成長すると予測されています。

主な発展：

2023年6月、H&T Presspart社はL'Arboc社へのさらなる投資を計画。Ventolin定量吸入器アクチュエーターの世界の供給は、タラゴナのL'Arboc（Baix Penedes）で製造されています。H&Tプレスパート社は、射出成型プラスチック製ドラッグデリバリー部品およびデバイスの年間生産量を合わせて10億個以上とし、この2年間でラルボック工場に2,000万ユーロ以上を投資し、生産能力を3,000平方メートルのクリーンルーム生産設備まで拡張しました。

2023年2月、Teva Pharmaceutical Industries Ltd.の米国関連会社であるTeva Pharmaceuticals USA, Inc.は、テキサス州サンアントニオで2月24日から27日まで開催される米国アレルギー・喘息・免疫学会（AAAAI）2023年年次総会で、デジヘイラーシステムに関する新たなデータを発表すると発表しました。このデータには、CONNECT2臨床試験プログラムから得られた知見に加え、患者や医療従事者によるスマート吸入器システムの実際の使用に関する情報が含まれます。デジヘイラー・システムは、患者や医師が喘息管理をサポートし、個別の治療計画を立てるのに役立つ客観的な吸入イベントデータを提供するセンサーを内蔵した最初で唯一のスマート吸入器システムです。

2022年12月、オーストラリアの医療用大麻会社ECS Botanics社は、薬用ドライフラワー用のヴェポライザー装置を供給すると発表しました。同社は、定量投与が可能なスマート吸入器と関連ソフトウェアを、まだ名前の知られていない会社から輸入し供給する契約を結んだとしています。

レポート内容

• 地域および国レベルセグメントの市場シェア評価
• 新規参入企業への戦略的提言
• 2021年、2022年、2023年、2026年、2030年の市場データを網羅
• 市場動向（市場促進要因、阻害要因、機会、脅威、課題、投資機会・促進要因、および推奨事項）
• 市場推定に基づく主要ビジネスセグメントにおける戦略的提言
• 主要な共通トレンドをマッピングした競合情勢
• 詳細な戦略、財務、最近の動向を含む企業プロファイル
• 最新の技術動向をマッピングしたサプライチェーン動向

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下のいずれかの無料カスタマイズオプションをご提供いたします：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界のスマート吸入器市場：製品別

• 吸入器
  • 乾燥粉末吸入器（DPI）
  • 定量吸入器（MDI）
• ネブライザー

第6章 世界のスマート吸入器市場：適応症別

• 喘息
• 慢性閉塞性肺疾患（COPD）

第7章 世界のスマート吸入器市場：流通チャネル別

• 病院薬局
• 小売薬局
• オンライン薬局

第8章 世界のスマート吸入器市場：エンドユーザー別

• 病院
• ホームケア設定
• 呼吸器ケアセンター
• その他のエンドユーザー

第9章 世界のスマート吸入器市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイル

• H&T Presspart Manufacturing Ltd.
• 3M Health Care Limited
• Adherium Limited
• AireHealth, Inc.
• Amiko Digital Health Limited
• AstraZeneca, Inc.
• Boehringer Ingelheim GmbH
• Cognita Labs, LLC
• Cohero Health LLC
• FindAir Sp. z o.o
• GlaxoSmithKline plc
• Novartis AG
• OPKO Health Inc
• Personal Air Quality Systems Private Limited
• Philip Morris International Inc.（Vectura Group Plc）
• Pneuma Respiratory, Inc.
• Propeller Health
• Teva Pharmaceuticals Industries Ltd.

List of Tables

• Table 1 Global Smart Inhalers Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Smart Inhalers Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Smart Inhalers Market Outlook, By Inhalers (2021-2030) ($MN)
• Table 4 Global Smart Inhalers Market Outlook, By Dry Powdered Inhalers (DPIs) (2021-2030) ($MN)
• Table 5 Global Smart Inhalers Market Outlook, By Metered Dose Inhalers (MDI's) (2021-2030) ($MN)
• Table 6 Global Smart Inhalers Market Outlook, By Nebulizers (2021-2030) ($MN)
• Table 7 Global Smart Inhalers Market Outlook, By Indication (2021-2030) ($MN)
• Table 8 Global Smart Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 9 Global Smart Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 10 Global Smart Inhalers Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 11 Global Smart Inhalers Market Outlook, By Hospitals Pharmacies (2021-2030) ($MN)
• Table 12 Global Smart Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 13 Global Smart Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
• Table 14 Global Smart Inhalers Market Outlook, By End User (2021-2030) ($MN)
• Table 15 Global Smart Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 16 Global Smart Inhalers Market Outlook, By Homecare Settings (2021-2030) ($MN)
• Table 17 Global Smart Inhalers Market Outlook, By Respiratory Care Centers (2021-2030) ($MN)
• Table 18 Global Smart Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 19 North America Smart Inhalers Market Outlook, By Country (2021-2030) ($MN)
• Table 20 North America Smart Inhalers Market Outlook, By Product (2021-2030) ($MN)
• Table 21 North America Smart Inhalers Market Outlook, By Inhalers (2021-2030) ($MN)
• Table 22 North America Smart Inhalers Market Outlook, By Dry Powdered Inhalers (DPIs) (2021-2030) ($MN)
• Table 23 North America Smart Inhalers Market Outlook, By Metered Dose Inhalers (MDI's) (2021-2030) ($MN)
• Table 24 North America Smart Inhalers Market Outlook, By Nebulizers (2021-2030) ($MN)
• Table 25 North America Smart Inhalers Market Outlook, By Indication (2021-2030) ($MN)
• Table 26 North America Smart Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 27 North America Smart Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 28 North America Smart Inhalers Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 29 North America Smart Inhalers Market Outlook, By Hospitals Pharmacies (2021-2030) ($MN)
• Table 30 North America Smart Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 31 North America Smart Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
• Table 32 North America Smart Inhalers Market Outlook, By End User (2021-2030) ($MN)
• Table 33 North America Smart Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 34 North America Smart Inhalers Market Outlook, By Homecare Settings (2021-2030) ($MN)
• Table 35 North America Smart Inhalers Market Outlook, By Respiratory Care Centers (2021-2030) ($MN)
• Table 36 North America Smart Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 37 Europe Smart Inhalers Market Outlook, By Country (2021-2030) ($MN)
• Table 38 Europe Smart Inhalers Market Outlook, By Product (2021-2030) ($MN)
• Table 39 Europe Smart Inhalers Market Outlook, By Inhalers (2021-2030) ($MN)
• Table 40 Europe Smart Inhalers Market Outlook, By Dry Powdered Inhalers (DPIs) (2021-2030) ($MN)
• Table 41 Europe Smart Inhalers Market Outlook, By Metered Dose Inhalers (MDI's) (2021-2030) ($MN)
• Table 42 Europe Smart Inhalers Market Outlook, By Nebulizers (2021-2030) ($MN)
• Table 43 Europe Smart Inhalers Market Outlook, By Indication (2021-2030) ($MN)
• Table 44 Europe Smart Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 45 Europe Smart Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 46 Europe Smart Inhalers Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 47 Europe Smart Inhalers Market Outlook, By Hospitals Pharmacies (2021-2030) ($MN)
• Table 48 Europe Smart Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 49 Europe Smart Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
• Table 50 Europe Smart Inhalers Market Outlook, By End User (2021-2030) ($MN)
• Table 51 Europe Smart Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 52 Europe Smart Inhalers Market Outlook, By Homecare Settings (2021-2030) ($MN)
• Table 53 Europe Smart Inhalers Market Outlook, By Respiratory Care Centers (2021-2030) ($MN)
• Table 54 Europe Smart Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 55 Asia Pacific Smart Inhalers Market Outlook, By Country (2021-2030) ($MN)
• Table 56 Asia Pacific Smart Inhalers Market Outlook, By Product (2021-2030) ($MN)
• Table 57 Asia Pacific Smart Inhalers Market Outlook, By Inhalers (2021-2030) ($MN)
• Table 58 Asia Pacific Smart Inhalers Market Outlook, By Dry Powdered Inhalers (DPIs) (2021-2030) ($MN)
• Table 59 Asia Pacific Smart Inhalers Market Outlook, By Metered Dose Inhalers (MDI's) (2021-2030) ($MN)
• Table 60 Asia Pacific Smart Inhalers Market Outlook, By Nebulizers (2021-2030) ($MN)
• Table 61 Asia Pacific Smart Inhalers Market Outlook, By Indication (2021-2030) ($MN)
• Table 62 Asia Pacific Smart Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 63 Asia Pacific Smart Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 64 Asia Pacific Smart Inhalers Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 65 Asia Pacific Smart Inhalers Market Outlook, By Hospitals Pharmacies (2021-2030) ($MN)
• Table 66 Asia Pacific Smart Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 67 Asia Pacific Smart Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
• Table 68 Asia Pacific Smart Inhalers Market Outlook, By End User (2021-2030) ($MN)
• Table 69 Asia Pacific Smart Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 70 Asia Pacific Smart Inhalers Market Outlook, By Homecare Settings (2021-2030) ($MN)
• Table 71 Asia Pacific Smart Inhalers Market Outlook, By Respiratory Care Centers (2021-2030) ($MN)
• Table 72 Asia Pacific Smart Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 73 South America Smart Inhalers Market Outlook, By Country (2021-2030) ($MN)
• Table 74 South America Smart Inhalers Market Outlook, By Product (2021-2030) ($MN)
• Table 75 South America Smart Inhalers Market Outlook, By Inhalers (2021-2030) ($MN)
• Table 76 South America Smart Inhalers Market Outlook, By Dry Powdered Inhalers (DPIs) (2021-2030) ($MN)
• Table 77 South America Smart Inhalers Market Outlook, By Metered Dose Inhalers (MDI's) (2021-2030) ($MN)
• Table 78 South America Smart Inhalers Market Outlook, By Nebulizers (2021-2030) ($MN)
• Table 79 South America Smart Inhalers Market Outlook, By Indication (2021-2030) ($MN)
• Table 80 South America Smart Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 81 South America Smart Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 82 South America Smart Inhalers Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 83 South America Smart Inhalers Market Outlook, By Hospitals Pharmacies (2021-2030) ($MN)
• Table 84 South America Smart Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 85 South America Smart Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
• Table 86 South America Smart Inhalers Market Outlook, By End User (2021-2030) ($MN)
• Table 87 South America Smart Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 88 South America Smart Inhalers Market Outlook, By Homecare Settings (2021-2030) ($MN)
• Table 89 South America Smart Inhalers Market Outlook, By Respiratory Care Centers (2021-2030) ($MN)
• Table 90 South America Smart Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 91 Middle East & Africa Smart Inhalers Market Outlook, By Country (2021-2030) ($MN)
• Table 92 Middle East & Africa Smart Inhalers Market Outlook, By Product (2021-2030) ($MN)
• Table 93 Middle East & Africa Smart Inhalers Market Outlook, By Inhalers (2021-2030) ($MN)
• Table 94 Middle East & Africa Smart Inhalers Market Outlook, By Dry Powdered Inhalers (DPIs) (2021-2030) ($MN)
• Table 95 Middle East & Africa Smart Inhalers Market Outlook, By Metered Dose Inhalers (MDI's) (2021-2030) ($MN)
• Table 96 Middle East & Africa Smart Inhalers Market Outlook, By Nebulizers (2021-2030) ($MN)
• Table 97 Middle East & Africa Smart Inhalers Market Outlook, By Indication (2021-2030) ($MN)
• Table 98 Middle East & Africa Smart Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 99 Middle East & Africa Smart Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 100 Middle East & Africa Smart Inhalers Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 101 Middle East & Africa Smart Inhalers Market Outlook, By Hospitals Pharmacies (2021-2030) ($MN)
• Table 102 Middle East & Africa Smart Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 103 Middle East & Africa Smart Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
• Table 104 Middle East & Africa Smart Inhalers Market Outlook, By End User (2021-2030) ($MN)
• Table 105 Middle East & Africa Smart Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 106 Middle East & Africa Smart Inhalers Market Outlook, By Homecare Settings (2021-2030) ($MN)
• Table 107 Middle East & Africa Smart Inhalers Market Outlook, By Respiratory Care Centers (2021-2030) ($MN)
• Table 108 Middle East & Africa Smart Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Smart Inhalers Market is accounted for $1.42 billion in 2023 and is expected to reach $2.60 billion by 2030 growing at a CAGR of 9% during the forecast period. Smart inhalers are gadgets made to pair with a mobile app via Bluetooth in order to manage chronic respiratory conditions effectively and enhance patients lifestyles. Additionally, based on a user's past history of dosage administration, these smart devices are able to send reminders and alerts to them. Asthma, cystic fibrosis, and chronic obstructive pulmonary disorders, among other respiratory illnesses, are becoming more common, which has caused an exponential rise in the demand for smart inhalers.

According to the WHO 2021 report, asthma is a major noncommunicable disease (NCD), affecting both children and adults, and has affected an estimated 262 million people in 2019 and caused 461000 deaths in the same year.

Market Dynamics:

Driver:

Rising incidence of asthma

Asthma and COPD are becoming more common due to an increase in air pollution and smoking habits, which is driving market demand for smart inhalers. The ODPHP Office of Disease Prevention and Health Promotion estimates that there will be over 339 million asthma patients worldwide in 2020, of whom 25 million are Americans with a COPD diagnosis of 14.8 million. Asthma is the most prevalent disease among children and the elderly. This non-communicable disease is spreading due to an increase in smoking habits and rising levels of global air pollution.

Restraint:

Risk of data leakage

The risk of data leakage and misuse has increased significantly as a result of smart inhalers' wireless connectivity and ability to record the patient's data. Additionally, the smart inhaler has a very low level of patient and physician acceptance, which is anticipated to impede market expansion.

Opportunity:

Growing Use of digital technology in medical devices

During the forecast period, it is anticipated that rising digital technology adoption in medical devices and the effectiveness of drug delivery devices in therapeutic measures will accelerate market growth. In addition to this, it is predicted that an increase in the prevalence of respiratory conditions like asthma and COPD will present a significant opportunity for the increased adoption of digital inhalers. For instance, a study by the Centers for Disease Control and Prevention (CDC) estimated that in 2016, there were 26.5 million asthma sufferers in the United States. The aforementioned factors will significantly fuel the market expansion of these smart inhalers.

Threat:

Existence of alternative manual inhalers

Despite the growing benefits of smart inhalers, the availability of manual inhalers as a substitute product may limit market expansion to some extent. Another significant factor impeding the market expansion of smart inhalers is the lack of awareness regarding the use of digital inhalers among the populace of developing economies.

COVID-19 Impact:

The global COVID-19 outbreak is anticipated to present lucrative growth opportunities for market participants in the smart inhaler space. Due to the high risk of hospitalization from COVID-19 for patients with COPD and asthma, the pandemic had a positive effect on the market. Thus, the demand for or adoption of smart inhalers is rising at this time due to rising COVID-19 cases and the burden of respiratory disorders.

The hospitals pharmacies segment is expected to be the largest during the forecast period:

In the forecasted time frame, it is predicted that the hospital pharmacies segment will account for the largest market share. The patient population receiving treatments in hospital settings has easy access to hospital pharmacies. Additionally, a number of manufacturers of smart drug delivery systems have distribution agreements with these hospital pharmacies. Therefore, during the projection period, the aforementioned factors strongly suggest a positive growth trajectory for the market for hospital pharmacies that sell smart inhalers.

The chronic obstructive pulmonary disease (COPD) segment is expected to have the highest CAGR during the forecast period:

Due to expanding COPD patient populations worldwide, the market growth is anticipated to witness lucrative growth in the coming years. For instance, the World Health Organization estimates that the third leading cause of death worldwide in 2019 was COPD, which claimed the lives of over 3.23 million people. Furthermore, a number of risk factors, including prolonged tobacco use, indoor air pollution, harmful gases and particles, and occupational dust, influence the prevalence of COPD and necessitate ongoing care management. As a result, segmental demand will be driven over the anticipated period by the rising prevalence rate of COPD and the rising need for effective treatment.

Region with largest share:

The North America region market is estimated to witness the highest share of the global Smart Shelves market during the forecast period, which is attributed to increasing activities by key market players in countries in this region. The smart shelves market in North America involves the adoption and deployment of intelligent shelving systems that incorporate advanced technologies to enhance the shopping experience, improve inventory management, and provide real-time data analytics in retail environments. Retailers in North America are increasingly embracing automation and digitalization to streamline their operations and enhance customer engagement. Smart shelves offer real-time inventory tracking, enabling retailers to optimize stock levels, reduce out-of-stock situations, and improve overall inventory management efficiency.

Region with highest CAGR:

Due to its large elderly population, rising disposable incomes, rising healthcare costs, and numerous developmental initiatives, the Asia-Pacific region is expected to experience rapid growth. Regional growth will be aided by emerging economies' rising healthcare IT development expenditures. In addition, the markets for smart inhalers in Asia-Pacific are predicted to grow rapidly in India and China.

Key players in the market

Some of the key players profiled in the Smart Inhalers Market include H&T Presspart Manufacturing Ltd., 3M Health Care Limited, Adherium Limited, AireHealth, Inc., Amiko Digital Health Limited, AstraZeneca, Inc., Boehringer Ingelheim GmbH, Cognita Labs, LLC, Cohero Health LLC, FindAir Sp. z o.o, GlaxoSmithKline plc, Novartis AG, OPKO Health Inc, Personal Air Quality Systems Private Limited, Philip Morris International Inc. (Vectura Group Plc), Pneuma Respiratory, Inc., Propeller Health and Teva Pharmaceuticals Industries Ltd.

Key Developments:

In June 2023, H&T Presspart plans more investment in L'Arboc. The global supply of Ventolin metered-dose inhaler actuators are manufactured in in L'Arboc (Baix Penedes), Tarragona. With a combined annual production of more than 1,000 million units of injection-moulded plastic drug delivery components and devices, H&T Presspart has invested more than 20 million euros in its factory in L'Arboc in the last two years to expand its production capacity up to 3,000 square meters of cleanroom production facilities, with which to carry out new projects as they anticipate strong growth in the coming years.

In February 2023, Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced that new data on its Digihaler System will be presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) 2023 Annual Meeting, being held February 24-27 in San Antonio, Texas. The data includes findings from the CONNECT2 clinical trial program as well as information on patients and healthcare professionals' real-world use of the smart inhaler system. The Digihaler System is the first and only smart inhaler system with built-in sensors that provide objective inhaler event data to help patients and their doctors support asthma management and develop personalized treatment plans.

In December 2022, Australian medical cannabis company ECS Botanics has announced it will be supplying a vaporiser device for use with medicinal dried flower. The company says it has signed an agreement to import and supply a Smart Inhaler and associated software from an as yet un-named company that will provide metered-dose administration.

Products Covered:

• Inhalers
• Nebulizers

Indications Covered:

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

Distribution Channels Covered:

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies

End Users Covered:

• Hospitals
• Homecare Settings
• Respiratory Care Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026 and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Smart Inhalers Market, By Product

• 5.1 Introduction
• 5.2 Inhalers
  • 5.2.1 Dry Powdered Inhalers (DPIs)
  • 5.2.2 Metered Dose Inhalers (MDI's)
• 5.3 Nebulizers

6 Global Smart Inhalers Market, By Indication

• 6.1 Introduction
• 6.2 Asthma
• 6.3 Chronic Obstructive Pulmonary Disease (COPD)

7 Global Smart Inhalers Market, By Distribution Channel

• 7.1 Introduction
• 7.2 Hospitals Pharmacies
• 7.3 Retail Pharmacies
• 7.4 Online Pharmacies

8 Global Smart Inhalers Market, By End User

• 8.1 Introduction
• 8.2 Hospitals
• 8.3 Homecare Settings
• 8.4 Respiratory Care Centers
• 8.5 Other End Users

9 Global Smart Inhalers Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 H&T Presspart Manufacturing Ltd.
• 11.2 3M Health Care Limited
• 11.3 Adherium Limited
• 11.4 AireHealth, Inc.
• 11.5 Amiko Digital Health Limited
• 11.6 AstraZeneca, Inc.
• 11.7 Boehringer Ingelheim GmbH
• 11.8 Cognita Labs, LLC
• 11.9 Cohero Health LLC
• 11.10 FindAir Sp. z o.o
• 11.11 GlaxoSmithKline plc
• 11.12 Novartis AG
• 11.13 OPKO Health Inc
• 11.14 Personal Air Quality Systems Private Limited
• 11.15 Philip Morris International Inc. (Vectura Group Plc)
• 11.16 Pneuma Respiratory, Inc.
• 11.17 Propeller Health
• 11.18 Teva Pharmaceuticals Industries Ltd.